Skip to Main Content
Table 1—

Basic details of study participants, prevalence of pain, and prevalence of PDPN

Population break downn (%)
Practice population (“list size”)  
    Total 8,531 
Diabetes register  
    Total 385 
    Known to have type 1 diabetes 28 
    Known to have type 2 diabetes 354 
    Found not to have diabetes 
    Deceased 
Study sample (phase 1)  
    Potentially eligible 353 
    Nonresponders (25) and those unable to respond (2) 27 
    Responders 326 (92.7) 
        Reported pain 208 (63.8) 
        Did not report pain 118 (36.2) 
Study sample (phase 2)  
    Eligible 326 
    Attended for assessment 269 (82.5) 
        Neuropathic pain 51 (19.0) 
        Nonneuropathic pain 99 (36.8) 
        Mixed pain 20 (7.4) 
        No pain 99 (36.8) 
Population break downn (%)
Practice population (“list size”)  
    Total 8,531 
Diabetes register  
    Total 385 
    Known to have type 1 diabetes 28 
    Known to have type 2 diabetes 354 
    Found not to have diabetes 
    Deceased 
Study sample (phase 1)  
    Potentially eligible 353 
    Nonresponders (25) and those unable to respond (2) 27 
    Responders 326 (92.7) 
        Reported pain 208 (63.8) 
        Did not report pain 118 (36.2) 
Study sample (phase 2)  
    Eligible 326 
    Attended for assessment 269 (82.5) 
        Neuropathic pain 51 (19.0) 
        Nonneuropathic pain 99 (36.8) 
        Mixed pain 20 (7.4) 
        No pain 99 (36.8) 
Close Modal

or Create an Account

Close Modal
Close Modal